News | November 02, 2008

FDA Clears Aurora’s Spectroscopy for Use with Breast MRI

November 03, 2008 – The FDA has given 501(k) clearance to the Aurora 1.5Tesla Dedicated Breast MRI System for AuroraSPECTROSCOPY, Aurora Imaging Technology’s breast magnetic resonance (MR) spectroscopy package.

The availability of AuroraSPECTROSCOPY will provide Aurora Breast MRI the capability to perform in vivo breast MR spectroscopy (MRS) and MR spectroscopic imaging (MRSI). AuroraSPECTROSCOPY was developed to supplement Aurora Breast MRI by further improving the image specificity of this groundbreaking technology. The Aurora Breast MRI remains the only FDA-cleared dedicated breast MRI system specifically designed for the detection, diagnosis and management of breast disease alone.

Although the use of spectroscopy is in its very early stages for the indication of breast cancer, clinical studies have supported the potential of spectroscopy to improve image specificity in detecting malignant breast tissue.

For more information: www.auroramri.com

Related Content

Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Study Finds Women With High Breast Cancer Risk Declining MRI Screening
News | MRI Breast | October 31, 2017
Some women, because of genetic predisposition, personal or family history, have a higher than average lifetime risk of...
Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives
breast MRI, new AB-MR exam protocol, Via Radiology, cancer detection, dense breasts, women's health
News | MRI Breast | February 07, 2017
A newly developed breast magnetic resonance imaging (MRI) exam protocol, the first of its kind being offered in the...
News | MRI Breast | June 27, 2016
A new phase 1 clinical trial from Brigham and Women's Hospital published in Radiology on June 22 evaluated the...
Overlay Init